MoonLake Immunotherapeutics (MLTX) Sector
Health Care

(Current) $13.41
0.21 (1.59%) Open Price: 13.15

MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company unlocking the potential of Sonelokimab, the novel investigational Nanobody® for the treatment of inflammation, to revolutionize outcomes for patients

(11/24/25) $13.15
(11/25/25) $13.20
(11/25/25) (Qty.)2,092,795
(11/24/25) $12.68
(11/24/25) $13.25
(11/09/25) $10.52
(11/16/25) $13.99
Stocktwits
LetsEncrypt SSL Secure Stripe Payment Processing